Pandoraea apista Coenye et al. (ATCC® BAA-106)

Strain Designations: CDC G3307 [89A-3201]  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Deposited As Lauromonas paucioxidans
Strain Designations CDC G3307 [89A-3201]
Isolation
Blood - human
California,
isolation date: 1969
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Antibiotic Resistance
Resistant to ampicillin
Resistant to cefazolin
Medium ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor RS Weyant
Special Collection NCRR Contract
Chain of Custody
ATCC <<--RS Weyant<<--California State Department of Health 89A-3201
Isolation
Blood - human
California,
isolation date: 1969
Year of Origin 1969
References

Daneshvar MI, et al. Assignment of cdc weak oxidizer group 2 (wo-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J. Clin. Microbiol. 39: 1819-1826, 2001. PubMed: 11325997

blood from a 66-year-old woman with chronic obstructive pulmonary disease, California State Department of Health

Cross References

Nucleotide (GenBank) : AF247699 Pandoraea sp. G3307 16S ribosomal RNA gene, partial sequence.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation